ArticleBioactive materials2026
Mitochondrial micro-nano reactors via enhancing mitochondrial transfer and mitophagy for alleviating metabolic crisis.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Energy metabolic dysfunction is a major cause of impaired chronic wounds healing, in which disrupted mitochondrial transfer and autophagy imbalance further aggravate the cellular energy crisis. In this study, single-cell RNA sequencing (scRNA-seq) of clinical diabetic wound samples first identified a pivotal role for macrophage-to-fibroblast mitochondrial transfer in wound healing. This finding was further validated using diabetic wound models and histological analyses, highlighting these processes as potential therapeutic targets for alleviating energy metabolic stress. Based on these findings, we innovatively developed a mitochondrial micro-nano reactor (MtNR) that alleviates the energy metabolic crisis by concurrently enhancing mitochondrial transfer and autophagy. First, hypoxic-preconditioning combined with gene-edited techniques was used to generate M2 macrophage-derived mitochondria-trained apoptotic bodies (mABs). Subsequently, mABs were conjugated with piezoelectric short fibers (PSFS) via copper-free strain-promoted azide-alkyne cycloaddition (SPAAC) click chemistry to self-assemble into MtNR. This system promotes intercellular mitochondrial transport through the Miro1-mitochondria-dynein-microtubule complex. It also generates bionic electrical signals via mechano-electrical conversion, thereby restoring Pink1-Parkin-P62/SQSTM1-LC3-mediated mitophagy and mitochondrial homeostasis. In a diabetic mouse wound model, MtNR restored mitochondrial morphology, enhanced cellular energy biogenesis, reduced p62 accumulation, increased LC3 expression, and significantly promoted tissue repair, providing a promising therapeutic strategy for addressing the energy deficit in diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.